Dystrophic Epidermolysis Bullosa Research Association (DEBRA) Research and the University Medical Center Groningen (UMCG), ...

Novartis has announced that ianalumab has received Breakthrough Therapy designation from the US FDA to treat Sjögren’s disease.

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates ...

NanoSyrinx has announced the appointment of Thomas J Farrell as its new CEO.

Learn how a next-generation approach to field training – powered by Generative AI (GenAI) and lifelike avatar simulations and ...

Novo Nordisk’s Wegovy (semaglutide injection) has received a new approval from the Medicines and Healthcare products ...

The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m ...

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, ...

The terms of the agreement state that AbbVie will provide lower-priced prescription drugs through the Medicaid programme. It ...

Colorectal cancer is the third most common cancer globally, with approximately 1.8 million people diagnosed in 2022 ...

For decades, pharma communications spoke the language of health systems, designed to inform healthcare professionals, ...

Eli Lilly has announced that it has entered into a definitive agreement to acquire Ventyx Biosciences, a biopharmaceutical ...